Clinical Trial Update: Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC [Phase 3]

View source ↗

Summary

A Phase 3 trial update evaluating cetuximab with pembrolizumab or finotonlimab plus chemotherapy in recurrent/metastatic head and neck squamous cell carcinoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• Finotonlimab
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Ji Dongmei | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 3 | Status: NOT_YET_RECRUITING